Faculty, Staff and Student Publications
Publication Date
4-1-2024
Journal
Journal of Pediatric Hematology / Oncology
Abstract
Spontaneous subgaleal hematoma in pediatric patients with sickle cell disease (SCD) is a rare occurrence that can present with symptoms mimicking ischemic stroke, a known complication of SCD. However, unlike ischemic stroke, subgaleal hematoma is nonlethal and can be managed conservatively without major sequelae. Here, we present the case of an adolescent with SCD who presented with 2 episodes of subgaleal and epidural hematomas, 2 years apart. The latter episode occurred while on crizanlizumab, an anti-P-selectin antibody, approved for use in SCD in 2019 to reduce the number of acute pain crises. We demonstrate the diagnosis of subgaleal hematoma and outline steps to conservative management which were safe and did not lead to focal neurologic deficits.
Keywords
acute soft head syndrome, epidural hematoma, sickle cell disease, subgaleal hematoma, thrombocytosis, vaso-occlusive crises
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Digestive, Oral, and Skin Physiology Commons, Digestive System Diseases Commons, Hematology Commons, Hemic and Lymphatic Diseases Commons, Oncology Commons, Pediatrics Commons
Comments
PMID: 38408160